A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
Clinical trial NCT05184816 · RECRUITING
Trial details
- NCT number
- NCT05184816
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-22
- Primary completion
- 2027-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.